BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35698854)

  • 1. Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis.
    Grant RRC; Khan TM; Gregory SN; Coakley BA; Hernandez JM; Davis JL; Blakely AM
    J Surg Oncol; 2022 Sep; 126(4):748-756. PubMed ID: 35698854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database.
    Reif de Paula T; Gorroochurn P; Simon HL; Haas EM; Keller DS
    Colorectal Dis; 2022 Jan; 24(1):40-49. PubMed ID: 34605166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?
    Massarweh NN; Haynes AB; Chiang YJ; Chang GJ; You YN; Feig BW; Cormier JN
    Ann Surg; 2015 Aug; 262(2):312-20. PubMed ID: 25185467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national evaluation of the predictors of compliance and survival from adjuvant chemotherapy in high-risk stage II colon cancer: A National Cancer Database (NCDB) analysis.
    Reif de Paula T; Gorroochurn P; Haas EM; Keller DS
    Surgery; 2022 Sep; 172(3):859-868. PubMed ID: 35864050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
    Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
    Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
    Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
    Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Chemotherapy Is Associated with Improved Survival for Stage III Colon Cancer When Initiated Beyond 8 Weeks.
    Ahmed FA; Wu VS; Kakish H; Rothermel L; Stein SL; Steinhagen E; Hoehn R
    J Gastrointest Surg; 2023 Sep; 27(9):1913-1924. PubMed ID: 37340108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in stage 1 colon cancer: Patient characteristics and survival analysis from the national cancer database.
    Hsu AT; Wolf JH; D'Adamo CR; Felton J; Paul S; Kumar P; Mavanur AA
    Surg Oncol; 2024 Jun; 54():102075. PubMed ID: 38636304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e29-e38. PubMed ID: 27663601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer.
    Ginesi MC; Bliggenstorfer JT; Kwesiga DM; Xu SH; Jodeh D; Eva Selfridge J; Stein SL; Steinhagen EF
    Ann Surg Oncol; 2023 Sep; 30(9):5511-5518. PubMed ID: 37249722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
    Cancer; 2020 Sep; 126(18):4136-4147. PubMed ID: 32697360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
    McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
    Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
    Chibaudel B; Henriques J; Rakez M; Brenner B; Kim TW; Martinez-Villacampa M; Gallego-Plazas J; Cervantes A; Shim K; Jonker D; Guerin-Meyer V; Mineur L; Banzi C; Dewdney A; Dejthevaporn T; Bloemendal HJ; Roth A; Moehler M; Aranda E; Van Cutsem E; Tabernero J; Schmoll HJ; Hoff PM; André T; de Gramont A
    JAMA Netw Open; 2020 Oct; 3(10):e2020425. PubMed ID: 33074326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.